Events

Recall of SPECTRA OPTIA APHERESIS SYSTEM - MAIN UNIT

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by TERUMO BCT (CANADA) INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    94041
  • Event Risk Class
    II
  • Event Initiated Date
    2010-12-16
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    The return line air detector is being added as a precautionary measure because the manufacturer has received reports where excessive clotting (incident rate 0.009%) in the extracorporeal circuit resulted in air entering the return line.

Device

SPECTRA OPTIA APHERESIS SYSTEM - MAIN UNIT
  • Model / Serial
    Model Catalog: 61000 (Lot serial: 1P00100-1P00719)
  • Product Description
    SPECTRA OPTIA APHERESIS SYSTEM
  • Manufacturer
    TERUMO BCT (CANADA) INC.

Manufacturer

TERUMO BCT (CANADA) INC.
  • Manufacturer Address
    MISSISSAUGA
  • Manufacturer Parent Company (2017)
    Terumo Corp.
  • Source
    HC